Trial Results Support Frontline Use of T-DM1 in HER2 ‐Positive Metastatic Breast Cancer

Treatment with trastuzumab emtansine demonstrated similar overall survival across 3 treatment arms of patients with HER2 ‐positive metastatic breast cancer.

Source: CancerNetwork - November 9, 2019 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news